These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 32124831)

  • 1. [Sex steroids and adipokines in men with prostate cancer and their relationship with obesity and metabolic syndrome].
    Borowski A; Siemińska L
    Wiad Lek; 2020; 73(1):180-187. PubMed ID: 32124831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesity and prostate cancer.
    Bandini M; Gandaglia G; Briganti A
    Curr Opin Urol; 2017 Sep; 27(5):415-421. PubMed ID: 28632505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity, metabolic syndrome, and prostate cancer.
    Hsing AW; Sakoda LC; Chua S
    Am J Clin Nutr; 2007 Sep; 86(3):s843-57. PubMed ID: 18265478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obesity, adipokines, and prostate cancer (review).
    Baillargeon J; Rose DP
    Int J Oncol; 2006 Mar; 28(3):737-45. PubMed ID: 16465380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity and prostate cancer: a role for adipokines.
    Mistry T; Digby JE; Desai KM; Randeva HS
    Eur Urol; 2007 Jul; 52(1):46-53. PubMed ID: 17399889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate cancer and metabolic syndrome: is there a link?
    McGrowder DA; Jackson LA; Crawford TV
    Asian Pac J Cancer Prev; 2012; 13(1):1-13. PubMed ID: 22502649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical, haemodynamic, anthropometric, metabolic and insulin profile of men with high-stage and high-grade clinical prostate cancer.
    Hammarsten J; Högstedt B
    Blood Press; 2004; 13(1):47-55. PubMed ID: 15083641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prostate cancer and metabolic syndrome].
    Nagamatsu H; Teishima J; Inoue S; Hayashi T; Matsubara A
    Nihon Rinsho; 2016 Jan; 74(1):149-54. PubMed ID: 26793896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Advances on the influence of adipose tissue on prostate cancer].
    López Fontana C; Maselli Artola ME; Vanrell Rodríguez MC; Di Milta Mónaco NA; Pérez Elizalde R; López Laur JD
    Actas Urol Esp; 2009 Mar; 33(3):242-8. PubMed ID: 19537061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity and prostate cancer.
    Presti JC
    Curr Opin Urol; 2005 Jan; 15(1):13-6. PubMed ID: 15586023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular risk of adipokines: a review.
    Dutheil F; Gordon BA; Naughton G; Crendal E; Courteix D; Chaplais E; Thivel D; Lac G; Benson AC
    J Int Med Res; 2018 Jun; 46(6):2082-2095. PubMed ID: 28974138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A stage-dependent link between metabolic syndrome components and incident prostate cancer.
    Hammarsten J; Damber JE; Haghsheno MA; Mellström D; Peeker R
    Nat Rev Urol; 2018 May; 15(5):321-333. PubMed ID: 29434372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose impairments and insulin resistance in prostate cancer: the role of obesity, nutrition and exercise.
    Di Sebastiano KM; Pinthus JH; Duivenvoorden WCM; Mourtzakis M
    Obes Rev; 2018 Jul; 19(7):1008-1016. PubMed ID: 29573216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An update on metabolic syndrome: Metabolic risk markers and adipokines in the development of metabolic syndrome.
    Kumari R; Kumar S; Kant R
    Diabetes Metab Syndr; 2019; 13(4):2409-2417. PubMed ID: 31405652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adipose tissue:Critical contributor to the development of prostate cancer.
    Uehara H; Kobayashi T; Matsumoto M; Watanabe S; Yoneda A; Bando Y
    J Med Invest; 2018; 65(1.2):9-17. PubMed ID: 29593201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Metabolic Syndrome in Prostate Cancer Development.
    Lifshitz K; Ber Y; Margel D
    Eur Urol Focus; 2021 May; 7(3):508-512. PubMed ID: 33994167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aromatase up-regulation, insulin and raised intracellular oestrogens in men, induce adiposity, metabolic syndrome and prostate disease, via aberrant ER-α and GPER signalling.
    Williams G
    Mol Cell Endocrinol; 2012 Apr; 351(2):269-78. PubMed ID: 22233684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adipose tissue, obesity and adipokines: role in cancer promotion.
    Booth A; Magnuson A; Fouts J; Foster M
    Horm Mol Biol Clin Investig; 2015 Jan; 21(1):57-74. PubMed ID: 25781552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obesity and prostate cancer: A narrative review.
    Wilson RL; Taaffe DR; Newton RU; Hart NH; Lyons-Wall P; Galvão DA
    Crit Rev Oncol Hematol; 2022 Jan; 169():103543. PubMed ID: 34808374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are findings from studies of obesity and prostate cancer really in conflict?
    Freedland SJ; Giovannucci E; Platz EA
    Cancer Causes Control; 2006 Feb; 17(1):5-9. PubMed ID: 16411047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.